Metropolitan Life Insurance Company (MetLife)’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,471
| Closed | -$133K | – | 605 |
|
|
2024
Q1 | $133K | Sell |
6,471
-335
| -5% | -$6.87K | 0.01% | 904 |
|
|
2023
Q4 | $146K | Hold |
6,806
| – | – | 0.01% | 890 |
|
|
2023
Q3 | $140K | Buy |
6,806
+354
| +5% | +$7.3K | 0.01% | 851 |
|
|
2023
Q2 | $190K | Buy |
6,452
+415
| +7% | +$12.2K | 0.01% | 694 |
|
|
2023
Q1 | $139K | Sell |
6,037
-688
| -10% | -$15.9K | 0.01% | 831 |
|
|
2022
Q4 | $187K | Buy |
6,725
+780
| +13% | +$21.7K | 0.01% | 745 |
|
|
2022
Q3 | $182K | Hold |
5,945
| – | – | 0.01% | 708 |
|
|
2022
Q2 | $175K | Buy |
5,945
+366
| +7% | +$10.8K | 0.01% | 757 |
|
|
2022
Q1 | $179K | Sell |
5,579
-18,510
| -77% | -$595K | 0.01% | 871 |
|
|
2021
Q4 | $1.07M | Hold |
24,089
| – | – | 0.01% | 905 |
|
|
2021
Q3 | $1.22M | Sell |
24,089
-708
| -3% | -$35.7K | 0.02% | 818 |
|
|
2021
Q2 | $1.95M | Buy |
24,797
+7,680
| +45% | +$602K | 0.03% | 536 |
|
|
2021
Q1 | $977K | Sell |
17,117
-737
| -4% | -$42.1K | 0.01% | 939 |
|
|
2020
Q4 | $1.5M | Hold |
17,854
| – | – | 0.02% | 624 |
|
|
2020
Q3 | $640K | Sell |
17,854
-1,558
| -8% | -$55.8K | 0.01% | 1038 |
|
|
2020
Q2 | $469K | Buy |
19,412
+3,727
| +24% | +$90.1K | 0.01% | 1255 |
|
|
2020
Q1 | $275K | Buy |
15,685
+536
| +4% | +$9.39K | 0.01% | 1399 |
|
|
2019
Q4 | $264K | Hold |
15,149
| – | – | ﹤0.01% | 1730 |
|
|
2019
Q3 | $232K | Hold |
15,149
| – | – | ﹤0.01% | 1778 |
|
|
2019
Q2 | $314K | Hold |
15,149
| – | – | 0.01% | 1590 |
|
|
2019
Q1 | $352K | Hold |
15,149
| – | – | 0.01% | 1523 |
|
|
2018
Q4 | $313K | Hold |
15,149
| – | – | 0.01% | 1527 |
|
|
2018
Q3 | $329K | Buy |
+15,149
| New | +$329K | 0.01% | 1661 |
|
|
2018
Q2 | – | Sell |
-8,769
| Closed | -$173K | – | 2466 |
|
|
2018
Q1 | $173K | Buy |
+8,769
| New | +$173K | ﹤0.01% | 1978 |
|